About Ezose Sciences Inc.

Ezose Sciences Inc. (pronounced ā-zose) is a glycomics-focused company that leverages its unique, high-throughput glycan analysis technology in two ways:

• as a platform to discover & develop new biomarkers and therapeutic targets
• as a glycoform analytical service to support biologic and biosimilar drug development

As a pioneer in glycan analysis methodologies, Ezose Sciences offers a proprietary new high-throughput solution that is compatible with complex biological samples and can deliver both qualitative and quantitative data on glycans of biological and clinical interest. Ezose operates under a flexible business model, with projects ranging from partnership to fee-for-service, all designed to meet the needs of our business partners.

A US-based company founded in 2009, Ezose Sciences is wholly owned by Shionogi & Co., Ltd, Osaka, Japan. The company was created to leverage glycan-profiling technology emerging from Japan’s prestigious Hokkaido University. Ezose Sciences’ unique alignment with Shionogi’s Diagnostics Division and its development and commercialization capabilities brings the promise of glycomics for biomarkers and personalized medicine into practical use for accelerating drug development and enhancing healthcare.

Ezose currently occupies 12,000 sf of fully-equipped laboratory and office space in Pine Brook, New Jersey.

Ezose Sciences represents a unique biotechnology venture, with science built on groundbreaking innovation from Japan, and business propelled by American entrepreneurial drive. With its facilities and headquarters in the US, Ezose Sciences is backed by the stability and resources of a leading international pharmaceutical company based in Japan.

Why Ezose Sciences?

Three core competencies position Ezose Sciences for success:

Technical Expertise. Ezose Sciences’ total process represents a new technology for analyzing glycans of biological and clinical interest. The company’s proprietary technology, collectively known as the GlycanMap® platform, combines a unique bead-based glycan capture technology, automated sample processing, high-throughput MALDI mass spectrometry and custom bioinformatics capabilities to deliver a high-throughput qualitative and quantitative mapping of glycans from diverse sample types.

Our People. Ezose Sciences’ management team has decades of experience in biological research. More than half of staff members hold doctorate degrees in Molecular Biophysics, Biochemistry and related scientific fields.

Entrepreneurial Spirit/Vision of Discovery. Ezose Sciences is a young, highly motivated and dynamic glycomics company. Ezose Sciences is focused on applying its novel GlycanMap® platform, a groundbreaking high-throughput Mass Spec-based glycan analysis system, to the discovery and development of new biomarkers, diagnostics, companion diagnostics and targets to advance medical practice and the treatment of disease. We also utilize our proprietary platform technologies for characterization of biologics and biosimilars.

Your Next Step

Our team will be happy to evaluate your individual research needs and discuss how our unique glycomics platform and capabilities can help advance your research and clinical programs. Contact Ezose Sciences today to get started.